Quarterly report · Q2
3840.TEDINET S100PMYN
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | −¥91m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | −¥322m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | −¥101m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥737m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥367m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥101m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥367m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥102m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥746m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥370m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥102m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | −¥370m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥1.3bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥1.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.2bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥324m | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥802m | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.0bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥470m | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥744m | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥193m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥345m | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥193m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥345m | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥211m | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥206m | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥287m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥836m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥361m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥24m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥52m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥137m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥999m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥419m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2.28 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.27 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.95 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.77 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.65 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.9% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 22
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥200,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥200,000 |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥52m |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥5m |
| jpcrp040300-q2r_E05674-000Sustainable Regenerative Medicine Related Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥300,000 |
| jpcrp040300-q2r_E05674-000Sustainable Regenerative Medicine Related Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥100,000 |
| jpcrp040300-q2r_E05674-000Sustainable Regenerative Medicine Related Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥200,000 |
| jpcrp040300-q2r_E05674-000Sustainable Regenerative Medicine Related Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥34m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥1.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥1.0bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥200,000 |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | −¥39m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥25m |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥268m |
| jpcrp040300-q2r_E05674-000Sustainable Regenerative Medicine Related Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥29m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | −¥297m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 452
| Item | Context | Value | Unit |
|---|---|---|---|
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |